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Psychiatric Manifestations of ATP13A2
Mutations
Bettina Balint, MD,1,2 Joana Damasio, MD,3,4 Francesca Magrinelli, MD,1,5 Rita Guerreiro, PhD,6 Jose Bras, PhD,6 and
Kailash P. Bhatia, FRCP1,*
ABSTRACT: Background: Biallelic mutations in ATP13A2 were identified as the cause of Kufor-Rakeb disease, a
pallido-pyramidal syndrome characterized by young-onset dystonia–parkinsonism with vertical supranuclear
gaze palsy, spasticity, and cognitive decline. The phenotypic spectrum has broadened since, but predominantly
psychiatric or behavioral manifestations have not been highlighted.
Cases: Here we report the clinical, radiological, and genetic findings in 2 unrelated patients with ATP13A2
mutations. One patient had a prominent behavioral (autistic spectrum) presentation and the other a psychiatric
(paranoid psychosis) presentation. Both had additional features, such as delayed milestones, ataxia, pyramidal
signs, upgaze restriction, or impaired cognition to varying extent, but these were partly subtle or developed
later in the disease course.
Conclusion: Prominent behavioral or psychiatric features can be the first or most prominent manifestation of
ATP13A2-related disease. They may be a diagnostic clue in patients with ataxia, spasticity, or parkinsonism and
may require an interdisciplinary neurological and psychiatric treatment approach.
Introduction
In 2006, biallelic mutations in ATP13A2 were identified as the
cause of Kufor-Rakeb disease, a pallido-pyramidal syndrome
characterized by young-onset dystonia-parkinsonism with verti-
cal supranuclear gaze palsy, spasticity and cognitive decline.1 The
phenotypic spectrum has broadened since to include also heredi-
tary spastic paraplegia (assigned locus symbol SPG 78),2,3 neu-
rodegeneration with brain iron accumulation,4 and neuronal
ceroid lipofuscinosis.5 With the advances in neurogenetics and
recent publications, it has become clear that ATP13A2 mutations
can cause a multisystem disorder affecting extrapyramidal, pyra-
midal, cerebellar, cortical, visual, and/or peripheral systems.
Nonetheless, predominantly psychiatric or behavioral manifesta-
tions have so far not been highlighted. This can lead to diagnos-
tic difficulty. Here we report 2 patients presenting with
prominent behavioral or psychotic problems and discuss the psy-
chiatric manifestations associated with ATP13A2-related disease.
Case Series
Case 1
This 18-year-old boy was the middle of 5 children of a consan-
guineous couple of Pakistani origin. His antenatal and perinatal
histories were unremarkable, but he had delayed motor and cog-
nitive milestones (walking at 3 years of age, talking at 5 years of
age). From the age of 11, he showed progressive gait and balance
difficulties and was using a wheelchair at age 13. Cognitively, he
was known to have learning difficulties, possibly also with a
deterioration in adolescence, but this was not formally tested. In
day-to-day life, one of the biggest problems was his difficulty in
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social interaction. Apart from the neurological symptoms, he was
investigated and diagnosed in infancy with laryngomalacia, gastro-
esophageal reflux, and hypospadia. Symptomatic treatment con-
sisted of trihexyphenidyl, baclofen, and levodopa. He had been
intensely investigated (including normal brain and spine magnetic
resonance imaging) without diagnosis when he presented in our
clinic. The predominant feature were stereotypies, which included
body rocking and pointing with the fingers, and abnormal behav-
ior in that he did not meet the eye and tended to be reclusive (see
Video S1). Although he did not speak in whole sentences, he was
responsive and followed simple commands. He had hyperreflexia
and a spastic gait with toe-walking. There was dystonic posturing
of the hands. He was a bit slow on finger-tapping, but did not dis-
play clear bradykinesia. In addition, there was a mild vertical gaze
palsy. A syndromic diagnosis of pallidopyramidal syndrome with
cognitive difficulties and vertical gaze palsy prompted genetic test-
ing for ATP13A2 mutations. The patient was found to have the
homozygous NM_022089.4: c.2218C > T (NM_022089.4:p.
Arg740Ter) mutation of the ATP13A2 gene. A dopamine trans-
porter scan (DaTscan) showed bilaterally reduced availability of the
presynaptic dopamine transporters. He was started on levodopa
with good response but also the development of dyskinesia. Formal
neuropsychometry showed prominent behavioral frontal signs and
impaired executive functioning, memory performance, and praxis.
Case 2
Case 2 is a 38-year-old female of Portuguese ancestry born to
nonconsanguineous parents. Developmental milestones were in
the normal range, but she was always clumsier and slower than
other children. School performance was average, with a college
degree obtained by the age of 24. From that time on, she devel-
oped a paranoid ideation, for example, that her husband was
cheating on her and work colleagues were going through her
notes and talked behind her back. She was later diagnosed with
bulimia nervosa and had to be hospitalized as a result of severe
hypoalbuminemia. At age 27, she developed psychosis with
complex persecutory delusions with episodes of visual hallucina-
tions. Antidepressants and neuroleptics were started, but even at
low doses there was marked sleepiness, slowness, and clumsiness.
The subsequent course was characterized by waxing and waning
of the psychiatric symptoms while medication was adjusted.
Eventually, treatment with aripiprazole stabilized her, but she
was unable to return to work and continued to have a clumsy
gait and difficulties with fine motor skills. At age 32, she had an
uneventful pregnancy and a healthy baby, and came to our
attention for the first time. At that time, she was taking
aripiprazole 2.5 mg once daily. Examination (see Video S2) rev-
ealed facial hypomimia with frontalis overactivity. Eye move-
ments were noticeable for upgaze restriction and a tendency to
blink and use a head thrust when initiating saccades. She had a
scanning dysarthria. The palmomental reflex could be elicited on
the left. There were global slowness and mild bradykinesia left
more than right and a mild irregular postural tremor. Pyramidal
signs involved hyperreflexia with brisk jaw jerk and deep tendon
reflexes, unsustained ankle clonus, and moderate leg spasticity.
She had a wide-based spastic gait without arm swing and was
unable to do tandem gait.
Formal neuropsychological assessment revealed multidomain
cognitive impairment with marked deficits in attention, moder-
ate deficits in executive function and verbal memory, and mild
deficits in visual memory.
Brain magnetic resonance imaging showed atrophy affecting
mainly the cerebellar vermis and hemispheres and to a lesser
extent both parietal lobes and the corpus callosum. Mild
hyperintensity of the forceps minor of the corpus callosum was
present, with a subtle “ear of the lynx” sign on the left
(see Fig. 1).
FIG. 1. Magnetic resonance imaging and dopamine transporter scan of case 2. Sagittal (A) and transversal (B) fluid attenuated inversion
recovery magnetic resonance imaging sequences show generalized brain atrophy with prominent parietal and cerebellar involvement as
well as an “ear of the lynx sign” on the left (B). Dopamine transporter single-photon emission computed tomography demonstrating
reduced tracer uptake predominantly on the left.
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A DaTscan revealed an asymmetric reduction (worse on left)
of dopamine uptake (see Fig. 1). A next-generation sequencing
panel for recessive ataxias in the patient and subsequent testing of
the unaffected parents disclosed 2 pathogenic variants in the
ATP13A2 gene in compound heterozygosity NM_022089.4:c.
[1472_1473del];[c.2567_2568del], giving rise to 2 copies of a
truncated protein (NM_022089.4:p.Gln491ArgfsTer29 and
NM_022089.4:p.Pro856ArgfsTer26). Aripiprazole was stopped,
resulting in only a mild improvement with regard to slowness.
After a second pregnancy, there was some deterioration in her
gait, but she remained ambulatory. Subsequently, there were
slowly progressive cognitive impairment and cerebellar signs
evolved to include upper and lower limb dysmetria. She also
developed distal lower limbs weakness. When she developed a
left-hand resting tremor and mild bradykinesia, treatment with
levodopa/carbidopa 300 mg/day was started and resulted in clin-
ical improvement. From the age of 32 until present she has
remained off antipsychotics without paranoid outbreaks.
Discussion
Here we present 2 unrelated patients with biallelic ATP13A2
mutations who presented with prominent psychiatric and behav-
ioral features. Case 1 manifested with prominent stereotypies and
autistic-like behavior in the context of a pallidopyramidal syn-
drome with cognitive difficulties and vertical gaze palsy. Case
2 came to medical attention because of psychiatric illness with
paranoid psychosis and bulimia nervosa and was seen by neurolo-
gists only 8 years later with a syndrome dominated by cerebellar
ataxia and spasticity.
Although theoretically these behavioral or psychiatric distur-
bances could have been coincidental, they are in line with previ-
ous observations of concomitant psychiatric features. For
example, hallucinations, often triggered or exacerbated by medi-
cation, have been mentioned in previous reports. Visual and
auditory hallucinations have been reported in the original Chil-
ean kindred, which led to the gene discovery underlying Kufor-
Rakeb disease6: 2 patients had (paranoid) auditory hallucinations
under treatment with trihexylphenidate, and 1 patient had visual
hallucinations without medication. Recent reports of ATP13A2
mutations manifesting as hereditary spastic paraplegia mentioned
acoustic hallucinations, delusions, or paranoid ideation (without
detailing their relation to medication).3,7 Visual hallucinations
and psychosis occurring during treatment with levodopa were
also noted in 2 other reports.8,9
Thus, it seems that psychosis and hallucinations are part of the
clinical spectrum of ATP13A2-related disease. Although in the
aforementioned cases these psychiatric manifestations developed
later in the disease course, in our case 2 they were the most
prominent presenting feature before the neurological syndrome
developed.
This observation has 2 implications. First, psychiatrists should
be aware of this as another neurological cause of psychiatric ill-
ness. Second, prominent psychosis and hallucinations might be
red flags and a clinical clue in the differential diagnosis of early-
onset parkinsonism, hereditary spastic paraplegia, or ataxia.
Similarly, behavioral problems have been noticed in previous
reports, encompassing mainly aggression,3,8 fatigue, and problems
with drive and motivation.3,6 Autistic spectrum presentations
with stereotypies have not been described so far with ATP13A2
mutations to the best of our knowledge, but this phenotype has
been recently recognized as part of a number of early-onset neu-
rodegenerative syndromes, such as those seen with WDR45 or
PLA2G6 mutations.10,11 The latter, just as ATP13A2-related
and PANK2-related disease, form part of the syndromes with
neuronal brain iron accumulation that may manifest with promi-
nent psychiatric features. Of note, however, the absence of iron
deposition is not an exclusion of these differential diagnoses, as
our cases illustrate. Lastly, Niemann Pick C is a treatable and thus
not-to-miss differential diagnosis of early-onset, progressive neu-
rological disease with prominent psychiatric features. The clinical
clue here is a vertical gaze palsy, but in contrast to case 1, particu-
larly affects downgaze.
In summary, we presented 2 cases of prominent behavioral
(autistic spectrum) and psychiatric (paranoid psychosis) presenta-
tions to highlight these possible manifestations of ATP13A2-
related disease. Further reports and studies will help clarify to
what extent these psychiatric aspects expand the clinical spectrum
of ATP13A2 mutations and should find consideration in the
workup of pediatric and adult patients from neurologist’s and
psychiatrist’s perspectives.
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Video S1. The video shows case 1. Although cooperative
and friendly, he has difficulties following even simple commands;
throughout the examination, he has stereotypies such as body
rocking, finger pointing, or other hand movements. He appears
to be hypomimic and has a mild upgaze restriction. There is a
suggestion of right more than left bradykinesia when he attempts
finger tapping, and left more than right dysmetria on finger–nose
testing. He has mild dystonic posturing of the hands, hyperre-
flexia, and a spastic gait.
Video S2. The video shows case 2. Her saccades show an
upgaze restriction in the vertical plane, and she has frontalis over-
activity. Finger–nose testing reveals left intention tremor and
mild dysmetria on the left more than on the right. Finger tapping
shows mild bradykinesia on the right more than left. There is
dysdiadochokinesia (right more than left), and leg agility is ham-
pered by cerebellar ataxia more prominent on the left, but slower
movements on the right. She has hyperreflexia with brisk
reflexes with pathological spread such as a crossed adductor
response. The gait is characterized by a combination of cerebellar
ataxia and spasticity.
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